The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection

Current Pharmaceutical Design

Volumn 11, Issue 31, 2005, Pages 4041-4046

  Gonzalez Cadavid, N F ^a,b   Rajfer, J ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Arteriosclerosis; Collagen; Corpora cavernosa; Erectile dysfunction; Fibrosis oxidative stress; Gene therapy; Penis; Peyronie's disease; Reactive oxygen species; Smooth muscle; Tunica albuginea

Indexed keywords

ARGININE; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE DONOR;

AGING; APOPTOSIS; CORPUS CAVERNOSUM; ENZYME INHIBITION; ERECTILE DYSFUNCTION; GENE EXPRESSION; MALE; MOLECULAR MECHANICS; NEUROTOXICITY; NONHUMAN; ORGANIC IMPOTENCE; OXIDATIVE STRESS; PENILE FIBROSIS; PENIS ERECTION; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SMOOTH MUSCLE RELAXATION; TUNICA ALBUGINEA;

AGING; FIBROSIS; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; NITRIC OXIDE SYNTHASE TYPE II; PENILE ERECTION; PENIS; TRANSCRIPTION, GENETIC;

EID: 27944448794     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161205774913372     Document Type: Review

References (62)

1. Schwentker A, Billiar TR. Inducible nitric oxide synthase: from cloning to therapeutic applications. World J Surg 2002; 26: 772-8.
2. Kroncke KD, Fehsel K, Suschek C, Kolb-Bachofen V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 2001; 1: 1407-20.
3. Ortiz PA, Garvin JL. Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 2003; 284: R628-38
4. O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 2001; 88: 12-21.
5. Mohanakumar KP, Thomas B, Sharma SM, Muralikrishnan D, Chowdhury R, Chiueh CC. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003; 111: 163-9.
6. González-Cadavid NF, Ignarro L, Rajfer J. Nitric oxide and cyclic GMP in the penis. Mol Urol 1999; 3: 51-9.
7. Gonzalez-Cadavid NF, Rajfer J. Therapy of erectile function: Potential future treatments. Endocrine 2004; 23: 167-76.
8. Hung A, Vernet D, Rajavashisht T, Rodriguez JA, Rajfer J, Gonzalez-Cadavid NF. Expression of the inducible nitric oxide synthase in smooth muscle cells from the rat penile corpora cavernosa. J Androl 1995; 16: 469-81.
9. Vernet D, Bonavera JJ, Swerdloff RS, González-Cadavid NF, Wang C. Spontaneous expression of inducible nitric oxide synthase (iNOS) in the hypothalamus and other brain regions of aging rats. Endocrinology 1998; 139: 3254-61.
10. Ferrini M, Wang C, Swerdloff R, Sinha Hikim AP, Gonzalez-Cadavid NF. Aging-related expression of inducible nitric oxide synthase (iNOS) and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Neuroendocrinolgy 2001; 74: 1-11.
11. Ferrini M, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Aging-related expression of inducible nitric oxide synthase (iNOS) and markers of tissue damage in the rat penis. Biol Reprod 2001; 64: 974-82.
12. Ferrini MG, Vernet D, Magee TR, Shahed A, Quian A, Rajfer J, et al. Antifibrotic role of inducible nitric oxide synthase (iNOS). Nitric Oxide 2002; 6: 1-12.
13. Gonzalez-Cadavid NF, Magee TR, Ferrini M, Qian A, Vernet D, Rajfer J. Gene expression in Peyronie's disease. In: "Update of Peyronie's disease", ed. by Nera A, Hellstrom W. Intn J Impot Res 2002; 14: 361-74.
14. Vernet D, Ferrini MG, Valente E, Magee TR, Bou-Gharios G, Rajfer J, et al. Effect of nitric oxide on fibroblast differentiation into myofibroblasts in cell cultures from the Peyronie's fibrotic plaque and in its rat model in vivo. Nitric Oxide 2002; 7: 262-76.
15. Gholami SS, Gonzalez-Cadavid NF, Lin C-S, Rajfer J, Lue TF. Peyronie's Disease: A review. J Urol 2002; 169: 1234-41.
16. Davila HH, Ferrini M, Rajfer J, Gonzalez-Cadavid NF. Fibrin induction of a Peyronie's-like plaque in the rat penile tunica albuginea. A new model for Peyronie's disease. BJU Int 2003; 91: 830-8.
17. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. PDE L-arginine and PDE inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 2003; 9: 229-44.
18. Gonzalez-Cadavid NF, Rajfer J. Molecular and cellular aspects of the pathophysiology of Peyronie's disease. Drug Discov Today. Dis Mechan 2004; 1: 99-104
19. Davila HH, Magee TR, Rajfer J, Gonzalez-Cadavid NF. Gene transfer of the inducible nitric oxide synthase (iNOS) cDNA regresses the fibrotic plaque in an animal model of Peyronie's disease. Biol Reprod 2004; 71: 1568-1577.
20. Ferrini MG, Davila HH, Valente EG, (Gonzalez-Cadavid NF*, Rajfer J*, *equal contributors). Aging-related induction of inducible nitric oxide synthase (iNOS) is vasculo-protective in the arterial media. Cardiovascular Res 2004; 61: 796-805.
21. Ghosh DK, Salerno JC. Nitric oxide synthases: domain structure and alignment in enzyme function and control. Front Biosci 2003; 8: d193-209.
22. Llorens S, Jordan J, Nava E. The nitric oxide pathway in the cardiovascular system. J Physiol Biochem 2002; 58: 179-88.
23. Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 1998; 95: 7625-30.
24. Tiscornia AC, Cayota A, Landoni AI, Brito C, Oppezzo P, Vuillier F, et al. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions. Leukemia 2004; 18: 48-56.
25. Keinanen R, Vartiainen N, Koistinaho J. Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. Gene 1999; 234: 297-305.
26. Feng X, Guo Z, Nourbakhsh M, Hauser H, Ganster R, Shao L, et al. Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc Natl Acad Sci USA 2002; 99: 14212-7.
27. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002; 303: 131-7.
28. Chen T, Zamora R, Zuckerbraun B, Billiar TR. Role of nitric oxide in liver injury. Curr Mol Med 2003; 3: 519-26.
29. Garban H, Marquez D, Magee T, Moody J, Rajavashisht T, Rodriguez JA, et al. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod 1997; 56: 954-63.
30. Tirney S, Mattes CE, Yoshimura N, Yokayama T, Ozawa H, Tzeng E, et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Mol Urol 2001; 5: 37-43.
31. Chancellor MB, Tirney S, Mattes CE, Tzeng E, Birder LA, Kanai AJ, et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int 2003; 91: 691-96.
32. Magee TR, Ferrini M, Garban H, Vernet D, Mitani K, Rajfer J, et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase cDNA. Biol Reprod 2002; 67: 1033-41.
33. Nangle MR, Cotter MA, Cameron NE. An in vitro study of corpus cavernosum and aorta from mice lacking the inducible nitric oxide synthase gene. Nitric Oxide 2003; 9: 194-200.
34. Burnett AL, Nelson RJ, Calvin DC, Liu JX, Demas GE, Klein SL, et al. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 1996; 2: 288-96.
35. González-Cadavid NF, Burnett AL, Magee T, Zeller CB, Vernet D, Gitter J, et al. Expression of penile neuronal nitric oxide synthase variants in the rat and mouse penile nerves. Biol Reprod 2002; 63: 704-14.
36. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997; 50: 1016-26.
37. Podlasek CA, Zelner DJ, Bervig TR, Gonzalez CM, McKenna KE, McVary KT. Characterization and localization of nitric oxide synthase isoforms in the BB/WOR diabetic rat. J Urol 2001; 166: 746-55.
38. Davila HH, Ferrini MG, Magee TR, Rajfer J, Gonzalez-Cadavid NF. Detrimental effect of cigarette smoking on erectile dysfunction in the rat is contingent to diabetes as co-morbidity. J Urol 2004; 171: 374, #1420.
39. Soriano FG, Virag L, Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med 2001; 79: 437-48.
40. Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, et al. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 2003; 200: 516-25.
41. Wang C, Sinha Hickim A, Ferrini M, Bonavera JJ, Vernet D, Leung A, et al. Male reproductive aging: using the Brown Norway rat as a model for man. In: Endocrine facets of aging in the human and experimental animal. Novartis Found Symp 2002; 242: 82-95
42. Lin CS, Ho HC, Chen KC, Lin G, Nunes L, Lue TF. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int 2002; 89: 955-60.
43. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol 2003; 23: 97-103.
44. Ihrig M, Dangler CA, Fox JG. Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas. Atherosclerosis 2001; 156: 103-7.
45. González-Cadavid NF, Ryndin I, Vernet D, Magee TR, Rajfer J. Presence of NMDA receptor subunits in the male lower urogenital tract. J Androl 2000; 21: 566-78.
46. Ferrini MG, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Penile neuronal nitric oxide synthase (PnNOS) and its regulatory proteins are present in hypothalamic and spinal cord regions involved in the control of penile erection. J Compar Neurol 2003; 458: 46-61.
47. Magee T, Zeller CB, Ferrini M, Davila HH, Vernet D, Burnett AL, et al. A protein inhibitor of NOS (PIN) is expressed in the rat and mouse penile nerves and co-localizes with penile neuronal NOS (PnNOS). Biol Reprod 2003; 68: 478-88.
48. Chang AY, Chan JY, Chan SH. Differential contributions of nitric oxide synthase isoforms at hippocampal formation to negative feedback regulation of penile erection in the rat. Br J Pharmacol 2002; 136: 1-8.
49. Siroky MR, Azadzoi KM. Vasculogenic erectile dysfunction: newer therapeutic strategies. J Urol 2003; 170: S24-9
50. Dey J, Shepherd MD. Evaluation and treatment of erectile dysfunction in men with diabetes mellitus. Mayo Clin Proc 2002; 77: 276-82.
51. Davila HH, Rajfer J, Gonzalez-Cadavid NF. Corporal veno-occlusive dysfunction in aging rats evaluation by cavernosometry and cavernosography. Urology 2004; 64: 1261-1266.
52. Burchardt T, Burchardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A, et al. Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol 2000; 164: 1807-11.
53. Shi HP, Most D, Efron DT, Tantry U, Fischel MH, Barbul A. The role of iNOS in wound healing. Surgery 2001; 130: 225-9.
54. Frank S, Kampfer H, Wetzler C, Pfeilschifter J. Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Int 2002; 61: 882-8.
55. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY. Oxygen free radicals and the penis. Exp Opin Pharmacother 2002; 3: 889-97.
56. Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC, et al. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol 2000; 163: 1992-8.
57. Bivalacqua TJ, Champion HC, Leungwattanakij S, Yang DY, Hyun JS, Abdel-Mageed AB, et al. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. J Androl 2001; 22: 497-506.
58. Austin PF, Casale AJ, Cain MP, Rink RC, Weintraub SJ. Lipopolysaccharide and inflammatory cytokines cause an inducible nitric oxide synthase-dependent bladder smooth muscle fibrotic response. J Urol 2003; 170: 645-8.
59. Felsen D, Dardashti K, Ostad M, Lemer ML, Gross SS, Chen J, et al. Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. J Urol 2003; 169: 1569-72.
60. Gouni-Berthold I, Sachinidis A. Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. Curr Pharm Design 2004; 10(11): 1261-71.
61. McCann SM, Haens G, Mastronardi C, Walczewska A, Karanth S, Rettori V, et al. The role of nitric oxide (NO) in control of LHRH release that mediates gonadotropin release and sexual behavior. Curr Pharm Design 2003; 9(5): 381-90.
62. Portaluppi F, Boari B, Manfredini R. Oxidative stress in essential hypertension. Curr Pharm Design 2004; 10(14): 1695-8.